UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence
Azenta (Nasdaq: AZTA) has been selected by UK Biocentre to provide its BioArc Ultra automated storage system for expanding large-scale sample storage capabilities. This addition complements seven existing BioArc Flex systems at their facility. The new system will be installed at UK Biocentre's 70,000 square-foot facility in Milton Keynes, England.
The BioArc Ultra will increase the facility's storage capacity by 16 million samples, adding to its current 35 million sample capacity. The system features high-density, fully automated -80°C storage with picking capability of up to 9 million picks per year. The solution includes FluidX 2D-coded screw-cap tubes for enhanced inventory management.
Key benefits include reduced footprint, lower labor requirements, and decreased electricity costs. The system employs an eco-friendly refrigeration system with zero Ozone Depletion Potential and zero Global Warming Potential. UK Biocentre will use this technology to support the Our Future Health study, which aims to develop new ways to prevent, detect, and treat diseases across up to 5 million people in the UK.
Azenta (Nasdaq: AZTA) è stata selezionata dal UK Biocentre per fornire il suo sistema di stoccaggio automatizzato BioArc Ultra per ampliare le capacità di stoccaggio di campioni su larga scala. Questa aggiunta si affianca ai sette sistemi BioArc Flex già esistenti nella loro struttura. Il nuovo sistema sarà installato presso la sede di UK Biocentre a Milton Keynes, in Inghilterra, che copre una superficie di 70.000 piedi quadrati.
Il BioArc Ultra aumenterà la capacità di stoccaggio della struttura di 16 milioni di campioni, aggiungendosi ai 35 milioni di campioni attualmente gestiti. Il sistema prevede un'archiviazione automatizzata ad alta densità a -80°C con capacità di prelievo fino a 9 milioni di prelievi all'anno. La soluzione include tubi con tappo a vite codificati in 2D FluidX per una gestione dell'inventario migliorata.
I principali vantaggi includono un ingombro ridotto, minori esigenze lavorative e costi energetici più bassi. Il sistema utilizza un sistema di refrigerazione ecologico con zero potenziale di deplezione dell'ozono e zero potenziale di riscaldamento globale. Il UK Biocentre utilizzerà questa tecnologia per supportare lo studio Our Future Health, che mira a sviluppare nuovi modi per prevenire, rilevare e trattare le malattie in un massimo di 5 milioni di persone nel Regno Unito.
Azenta (Nasdaq: AZTA) ha sido seleccionada por UK Biocentre para proporcionar su sistema de almacenamiento automatizado BioArc Ultra para ampliar la capacidad de almacenamiento de muestras a gran escala. Esta adición complementa a los siete sistemas BioArc Flex existentes en su instalación. El nuevo sistema se instalará en la instalación de UK Biocentre de 70,000 pies cuadrados en Milton Keynes, Inglaterra.
El BioArc Ultra incrementará la capacidad de almacenamiento de la instalación en 16 millones de muestras, sumándose a la capacidad actual de 35 millones de muestras. El sistema cuenta con almacenamiento automático de alta densidad a -80°C con capacidad de recogida de hasta 9 millones de recogidas al año. La solución incluye tubos con tapa de tornillo codificados en 2D FluidX para una mejor gestión del inventario.
Los principales beneficios incluyen una huella reducida, menores requisitos de mano de obra y costos de electricidad reducidos. El sistema emplea un sistema de refrigeración ecológico con cero potencial de agotamiento de ozono y cero potencial de calentamiento global. UK Biocentre utilizará esta tecnología para apoyar el estudio Our Future Health, que busca desarrollar nuevas formas de prevenir, detectar y tratar enfermedades en hasta 5 millones de personas en el Reino Unido.
아젠타(Azenta, Nasdaq: AZTA)는 대규모 샘플 저장 용량 확대를 위해 BioArc Ultra 자동 저장 시스템을 제공하기 위해 영국 생명과학 센터(UK Biocentre)에 선정되었습니다. 이 추가는 그들의 시설에 있는 기존 BioArc Flex 시스템 7개를 보완합니다. 새로운 시스템은 잉글랜드 밀턴킨스에 있는 70,000 제곱피트 규모의 UK Biocentre 시설에 설치될 예정입니다.
BioArc Ultra는 시설의 저장 용량을 1600만 샘플로 늘려 현재 3500만 샘플 용량에 추가됩니다. 이 시스템은 자동화된 고밀도 -80°C 저장 기능과 연간 최대 900만 회의 픽업 능력을 제공합니다. 이 솔루션은 개선된 재고 관리를 위해 FluidX 2D 코드화된 나사 뚜껑 튜브를 포함합니다.
주요 이점으로는 공간 절약, 낮은 노동 요구사항, 및 전기 비용 절감이 있습니다. 이 시스템은 오존 고갈 잠재력 및 지구 온난화 잠재력이 제로인 친환경 냉각 시스템을 사용합니다. UK Biocentre는 이 기술을 사용하여 영국의 최대 500만 명의 사람들을 대상으로 질병 예방, 탐지 및 치료의 새로운 방법을 개발하는 것을 목표로 하는 Our Future Health 연구를 지원할 것입니다.
Azenta (Nasdaq: AZTA) a été sélectionnée par le UK Biocentre pour fournir son système de stockage automatisé BioArc Ultra afin d'élargir ses capacités de stockage d'échantillons à grande échelle. Cet ajout complète les sept systèmes BioArc Flex déjà existants dans leur installation. Le nouveau système sera installé dans l'établissement de 70 000 pieds carrés du UK Biocentre à Milton Keynes, en Angleterre.
Le BioArc Ultra augmentera la capacité de stockage de l'établissement de 16 millions d'échantillons, s'ajoutant à sa capacité actuelle de 35 millions d'échantillons. Le système présente un stockage à haute densité entièrement automatisé à -80 °C avec une capacité de prélèvement allant jusqu'à 9 millions de prélèvements par an. La solution comprend des tubes à vis codés en 2D FluidX pour une gestion des stocks améliorée.
Les principaux avantages incluent une empreinte réduite, des exigences de main-d'œuvre plus faibles et des coûts d'électricité diminués. Le système utilise un système de refroidissement écologique avec un potentiel de déplétion de l'ozone et un potentiel de réchauffement global nuls. Le UK Biocentre utilisera cette technologie pour soutenir l'étude Our Future Health, qui vise à développer de nouvelles façons de prévenir, de détecter et de traiter les maladies chez jusqu'à 5 millions de personnes au Royaume-Uni.
Azenta (Nasdaq: AZTA) wurde vom UK Biocentre ausgewählt, um sein BioArc Ultra automatisiertes Lagersystem bereitzustellen, um die Speicherkapazitäten für großangelegte Proben zu erweitern. Diese Ergänzung ergänzt sieben bestehende BioArc Flex Systeme in ihrer Einrichtung. Das neue System wird in der 70.000 Quadratfuß großen Einrichtung des UK Biocentre in Milton Keynes, England, installiert.
Das BioArc Ultra wird die Speicherkapazität der Einrichtung um 16 Millionen Proben erhöhen und damit die derzeitige Kapazität von 35 Millionen Proben erweitern. Das System zeichnet sich durch eine hochdichte, vollautomatisierte Lagerung bei -80°C mit einer Abrufkapazität von bis zu 9 Millionen Abrufen pro Jahr aus. Die Lösung umfasst FluidX 2D-codierte Schraubverschlussröhrchen für ein verbessertes Inventarmanagement.
Zu den wichtigsten Vorteilen gehören ein reduzierter Platzbedarf, geringere Arbeitsanforderungen und niedrigere Stromkosten. Das System verwendet ein umweltfreundliches Kühlsystem mit null Ozonabbaupotential und null Treibhauspotential. Das UK Biocentre wird diese Technologie nutzen, um die Our Future Health-Studie zu unterstützen, die darauf abzielt, neue Wege zur Prävention, Diagnose und Behandlung von Krankheiten bei bis zu 5 Millionen Menschen im Vereinigten Königreich zu entwickeln.
- Secured major contract with UK Biocentre for BioArc Ultra system
- Expands existing relationship with UK Biocentre, which already uses seven BioArc Flex systems
- System provides significant operational cost savings through reduced labor, footprint, and electricity usage
- Technology supports large-scale research project involving up to 5 million people
- None.
Insights
This deal marks a strategic expansion of Azenta's footprint in the critical UK biobanking market, building upon an existing successful partnership. The selection of BioArc Ultra for the Our Future Health program, which aims to collect samples from up to 5 million people, positions Azenta to capture substantial recurring revenue through consumables like their FluidX tubes and ongoing maintenance services.
The technical specifications of BioArc Ultra - particularly its high-density storage capacity, advanced automation capabilities and eco-friendly features - address key industry pain points around operational efficiency and sustainability. This positions Azenta favorably against competitors in the rapidly growing biobanking market, projected to reach
Strategically, this installation strengthens Azenta's presence in the UK's life sciences ecosystem, potentially leading to additional opportunities as the country expands its biomedical research initiatives. The deal's significance extends beyond immediate revenue, as it:
- Validates Azenta's technology leadership in automated bio-storage
- Creates a high-profile reference site for future sales efforts
- Establishes a strong position in large-scale healthcare research projects
- Demonstrates the scalability of their automated storage solutions
The operational efficiencies provided by BioArc Ultra, including reduced footprint, labor and electricity costs, align with growing industry demands for cost-effective and sustainable sample management solutions. This positions Azenta to potentially secure similar large-scale deployments as other countries launch comparable healthcare research initiatives.
The BioArc Ultra will be installed into
The Ultra delivers significant operational efficiency benefits, including reduced footprint, labor requirements, and electricity costs as compared to other commercially available systems, and benefits
Dr. Tony Cox OBE, Chief Executive Officer of
"We are excited to support
To learn more about the BioArc Ultra, visit https://www.azenta.com/products/bioarc-ultra-high-density-80-c-automated-sample-storage-system.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research, and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.
About the
INVESTOR CONTACTS:
Yvonne Perron
Vice President, Financial, Planning & Analysis and Investor Relations
ir@azenta.com
PUBLIC RELATIONS CONTACT:
Renay Picard
Director of Marketing, Sample Management Solutions
renay.picard@azenta.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/uk-biocentre-selects-the-azenta-life-sciences-bioarc-ultra-automated-storage-system-to-advance-research-excellence-302359087.html
SOURCE Azenta
FAQ
What is the storage capacity expansion provided by Azenta's BioArc Ultra system at UK Biocentre?
What are the key operational benefits of AZTA's BioArc Ultra system?
How many sample picks per year can AZTA's BioArc Ultra system handle?
How many BioArc systems does UK Biocentre now have from AZTA?
What major research project will AZTA's BioArc Ultra system support at UK Biocentre?
